We are going through some challenges as Coronavirus spreads all over the world.It makes sense for us to be braced and have knowledge on best approaches to help our body fight the virus, in case it will be needed. We put together several informations and research content about supplements that can help fighting virus infections for you.



It is used to treat Myelofibrosis and Polycythaemia vera. Polycythemia vera is a rare, chronic blood cancer where the bone marrow produces too many red blood cells. Myelofibrosis is also a rare, chronic blood cancer. It can also “progress,” or get worse over time. For example, new symptoms may appear or existing symptoms may get worse.

Method of administration

Licensed for

  • HIV infection

Licensed dose

No information is available.

Status of clinical development for Coronaviruses

Ruxolitinib is currently clinically trialled for COVID-19.

Proposed dose for COVID-19

The dosage for clinical trail of COVID-19 is currently not available.

Go back to the overview